ClinConnect ClinConnect Logo
Search / Trial NCT05336682

Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp

Launched by CAIRO UNIVERSITY · Apr 18, 2022

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Lstr Lesion Sterilization And Tissue Repair Pulpectomy Zinc Oxide And Eugenol Irreversible Pulpitis Vital Primary Molars

ClinConnect Summary

This clinical trial is studying different treatment methods for children with inflamed pulp in their primary molars, a condition known as irreversible pulpitis. The trial compares three approaches: one where the dentist cleans the tooth and applies a special paste to help heal the remaining tissue; another where only part of the pulp is removed, and the base is covered with antibiotic paste; and a standard treatment called pulpectomy, which involves removing all the pulp and filling the space with a special material.

To participate, children must be between 4 to 10 years old and have specific types of dental issues, like deep cavities in their second primary molars that can still be treated. They should not have any known allergies to the materials used in the study or certain health conditions that could complicate treatment. Participants can expect to receive dental care tailored to their assigned group, with careful follow-up to monitor their recovery. This trial is currently recruiting, and it's an opportunity to explore new ways to treat dental pulp issues in young patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Molars should be restorable.
  • Mandibular second primary molars with deep caries, vital carious pulp exposure, irreversible pulpitis.
  • Mobility: Non or grade I.
  • Radiographic signs of minimal external root resorption.
  • Exclusion Criteria:
  • Children with known allergy to the agents used.
  • Children with infective endocarditis.
  • Refusal of participation.
  • Unable to attend follow-up visits.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Gihan M Abuelniel, Professor

Study Chair

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials